GmbH - European Pharma Licensing
GmbH - European Pharma Licensing
GmbH - European Pharma Licensing
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
19‐21 September 2011 X IPLS, Barcelona Final Delegate List<br />
Title Name Surname Job Title Company Name<br />
Mrs Jacqueline Hayes Global <strong>Licensing</strong> Manager 3M Health Care Ltd<br />
Ms Victoria Sessions Business Development Manager 3M Health Care Ltd<br />
Mr Cristiano Musso <strong>Licensing</strong> Director A. Menarini IFR<br />
Mr Gabriele Scali <strong>Licensing</strong> and Business Development Manager Abiogen <strong>Pharma</strong> SpA<br />
Mr Nicholas Franco EVP, Chief Business Development Officer Actelion Ltd<br />
Mr Emil Pot Director Business Development, Legal & IP ActoGeniX NV<br />
Mr Raul Navarro Business Development Manager Adamed Laboratorios (Spain)<br />
Mr John Dawson Chief Executive Officer Alliance <strong>Pharma</strong><br />
Mr Dan Thomas Business Development Director Alliance <strong>Pharma</strong>ceuticals Ltd<br />
Mr Jordi Sabe Associate Director, Head Strategic Transactions Almirall<br />
Mr Eduardo Sanchiz CEO Almirall<br />
Ms Nuria Assens New Projects Manager Almirall S.A.<br />
Mrs Sandra Blanqué Ros New Projects Manager Almirall S.A.<br />
Mr Jordi Cabot Head of New Projects & Market Research Almirall S.A.<br />
Mr Cesar de Oza Head Corporate Development, Marketed Products Almirall S.A.<br />
Ms Mercedes Diz Associate Director <strong>Licensing</strong> & Corporate Development Almirall S.A.<br />
Ms Maria Rita Luparini Senior Manager ‐ HQ Business Development Angelini<br />
Mr José Alarcón Marketing and Business Development Director Angelini Farmacéutica, S.A.<br />
Mrs Cecilia Häusermann <strong>Licensing</strong> Manager CEE Angelini Group<br />
Mr Angelo Guglielmotti <strong>Licensing</strong>‐In Manager Angelini‐Acraf SpA<br />
Mr Patrick Burgermeister Business Development Apeiron Biologics AG<br />
Mr Hans Loibner CEO Apeiron Biologics AG<br />
Mrs Nadine Maalouf Senior <strong>Licensing</strong> Manager Aptalis <strong>Pharma</strong><br />
Mr Pierre‐Hervé Brun Director Europe Business Development Aptalis <strong>Pharma</strong> SAS<br />
Mr Simon Bennett Consultant Arecor Ltd<br />
Mr Thomas Saylor Chief Executive Officer Arecor Ltd<br />
Mr Stafan Busch Vice President Strategic Planning & Portfolio Management AstraZeneca<br />
Mr Geoff Collett Regional Business Development Director Europe AstraZeneca<br />
Mr Michael Gross Head of Business Development AstraZeneca<br />
Mr Denis Peeters Finance Manager Business Development Europe AstraZeneca<br />
Mr Michio Tanaka Alliance Management Director AstraZeneca<br />
Mr Campbell Wilson Business Development Director, SPBD Oncology AstraZeneca<br />
Mr Juan Panos Business Development Manager ‐ Spain AstraZeneca Farmaceutica Spain, S.A.<br />
Mr Giuseppe Gugliotta Business Development & <strong>Licensing</strong> Manager AstraZeneca S.p.A.<br />
Mr Ian Evetts Managing Director Atebion BDS Ltd<br />
Ms Constanze Ulmer‐Eilfort Attorney Baker & McKenzie<br />
Mr Jürgen Langhärig Vice President Business Development Bavarian Nordic A/S<br />
Mr Carmelo Guerrero Business Development and <strong>Licensing</strong> Manager Bayer<br />
Mr Daniel Horn Senior Director Bayer Schering <strong>Pharma</strong> AG<br />
Mr Steven Short Managing Director Beacon <strong>Pharma</strong>ceuticals Ltd<br />
Mrs Joan Short Director of Legal Affairs Beacon <strong>Pharma</strong>ceuticals Ltd<br />
Ms Annika Eicke Berlin‐Chemie AG<br />
Ms Annegret Kramer Berlin‐Chemie AG<br />
Mr Bastian Wolter Business Development Manager Berlin‐Chemie AG<br />
Mrs Virtudes Garcia Project Holder BIOCOOP<br />
Mr Luis Castiñeiras Seijo Product Manager / Business Development Biofabri, S.L.<br />
Ms Mercedes Rodriguez Rojas Marketing Manager / Business Development Biofabri, S.L.<br />
1
19‐21 September 2011 X IPLS, Barcelona Final Delegate List<br />
Mr Ramon Brusco General Manager Bioselenia S.L.<br />
Mr Roberto Mancuso <strong>Licensing</strong> & Business Development Bioselenia Srl<br />
Mr Pierfrancesco Maschio Managing Director Bioselenia Srl<br />
Ms Petra Frick Corporate Director Business Development CHC Boehringer Ingelheim <strong>Pharma</strong> <strong>GmbH</strong> & Co. KG<br />
Mr Roland Schneider Head of Research for Marketing, Media & Sales/Business Development Boehringer Ingelheim <strong>Pharma</strong> <strong>GmbH</strong> & Co. KG<br />
Mr Martin Zoller Vice President Corporate CHC Business Development Boehringer Ingelheim <strong>Pharma</strong> <strong>GmbH</strong> & Co. KG<br />
Mr Rolf Fricker Vice President Booz & Company GnbH<br />
Mr Tim Fitzgerald Chief Executive Officer Bridgehead International<br />
Mr Jim Furniss Director, Global Market Access Strategy Bridgehead International<br />
Ms Annette Brinker Managing Director Brinker <strong>Pharma</strong> Consulting<br />
Mr Giorgio Bianchi Business Development Consultant BS&B<br />
Mr Ivan Csendes Business Development Consultant<br />
Mr Yashu Ondhia Managing Director Cambridge Healthcare Supplies Ltd<br />
Mr Eric Rambeaux Senior Practice Executive Campbell Alliance<br />
Ms Paloma Martinez Sánchez Regulatory and Business Development Director Cantabria <strong>Pharma</strong> S.L.U.<br />
Mr Luis Carro Area Sales Manager Chemo<br />
Mr Gerardo Dueso Commercial Director Chemo Ibérica, S.A.<br />
Mr Gonzalo Hernandez Herrero R&D & Strategic Planning Director Chemo Spain, S.L.<br />
Mr Jorge Lopez Garcia Business Development Chemo Spain, S.L.<br />
Mr José María Adalid Falcón Socio Director Cirex Consulting<br />
Mr Daniel Pavin Partner Covington & Burling<br />
Mr Matthew Roe Chief Business Officer Crescendo Biologics Ltd<br />
Mr Adolfo de Basilio D&A <strong>Pharma</strong><br />
Mr Hirokazu Kobayashi Director Business Development & <strong>Licensing</strong> Europe Daiichi Sankyo Europe <strong>GmbH</strong><br />
Ms Ginny Llobell Vice President Defined Health<br />
Mr Ed Saltzman President Defined Health<br />
Mr Philippe Gabant Head of Business Development Delphi Genetics<br />
Mr Guy Helin Chief Financial Officer Delphi Genetics<br />
Mr Harald Jainta Director Business Development Desitin Arzneimittel <strong>GmbH</strong><br />
Mrs Cristina Armandola B&D Manager Desma Healthcare<br />
Mr Claudio Moro General Manager Desma Healthcare<br />
Mr Andre Toussaint Managing Director Dr Kade <strong>Pharma</strong> <strong>GmbH</strong><br />
Mr Christoph Newzella Managing Director Dr. M. Newzella <strong>GmbH</strong><br />
Mr Henning Thiel Consultant Dr. M. Newzella <strong>GmbH</strong><br />
Mrs Anja Mandelkow‐Strozyk Managing Partner Dr. Oehmichen & Partner<br />
Mr Alexander Oehmichen Managing Partner Dr. Oehmichen & Partner<br />
Mr Giancarlo Mennella Managing Director Egamid Ltd<br />
Ms Carmen González Cortina Asesora Comercial Enterprise Ireland ‐ Oficina Comercial de Irlanda<br />
Mrs Daniela Sica Business Development Manager E‐<strong>Pharma</strong> Trento S.p.A.<br />
Mr Jaume Masana <strong>Licensing</strong> and Strategic Partnering Esteve<br />
Mr Xavier Pages Business Development, Strategic Planning & <strong>Licensing</strong> Esteve<br />
Mr Enric Turmo Senior <strong>Licensing</strong> Manager Esteve<br />
Mr Bruno Delie VP Business Development Ethypharm<br />
Mr Klaus Maleck Chief Financial Offer and Member of the Management Board Evotec<br />
Mr Paul Meng CEO ExperGen <strong>GmbH</strong><br />
Mr Nigel Sheail Deputy Director, Head of Global M&A F. Hoffman‐La Roche Ltd<br />
Mrs Loreto Alvarez‐Cedrón Rodriguez BD and L Manager Faes Farma, S.A.<br />
Mr Francisco Quintanilla General Manager Faes Farma, S.A.<br />
2
19‐21 September 2011 X IPLS, Barcelona Final Delegate List<br />
Mr Paul Ranson Partner Fasken Martineau LLP<br />
Mr Stuart Richards Partner Fasken Martineau LLP<br />
Ms Olga Fidalgo Corporate Director Business Development & <strong>Licensing</strong> Ferrer International, SA<br />
Mr Guillem Florit Business Development & <strong>Licensing</strong> Manager Ferrer International, SA<br />
Mr Rudy Thoma Managing Director Formula <strong>GmbH</strong><br />
Mr David Dasberg Vice President Business Development Fresenius Kabi Deutschland <strong>GmbH</strong><br />
Mr Sergi Aulinas General Manager Gebro <strong>Pharma</strong><br />
Ms Victoria Sevil Business Development Manager Gebro <strong>Pharma</strong><br />
Ms Emma Gasol Business Development Director, In‐<strong>Licensing</strong> Gebro <strong>Pharma</strong>, S.A.<br />
Ms Szilvia Endrényi Business Develompment Manager Gedeon Richter Iberica<br />
Ms Tracey Rand Business Development Director Genus <strong>Pharma</strong>ceuticals Ltd<br />
Mr Mario Ortúzar Business Development Manager GES Genéricos Españoles<br />
Mr Adam Hutchings UK Partner Global Market Access Solutions<br />
Mr Philippe Beaupere Head of Business Development Goldshield Group Ltd<br />
Mr David Phillips Business Development Manager Goldshield Group Ltd<br />
Mr Ulrich Granzer Granzer Regulatory Consulting & Services<br />
Ms Sascha Mielcarek Vice President Portfolio Management Grünenthal <strong>GmbH</strong><br />
Mr Mihalis Perdikoulis Associate Director Corporate <strong>Licensing</strong> Grünenthal <strong>GmbH</strong><br />
Mr Christoph Stolle Senior Vice President Commercial Department Grünenthal <strong>GmbH</strong><br />
Mr Dagmar Wolff Director Corporate <strong>Licensing</strong> Grünenthal <strong>GmbH</strong><br />
Mr Erik Bardrum Nielsen Director Scientific Assessment H. Lundbeck A/S<br />
Mr Christian Kanzelmeyer CEO hameln pharma plus <strong>GmbH</strong><br />
Mr Giulio Dosi Director Helsinn Healthcare S.A.<br />
Mrs Daniela Guerriero <strong>Licensing</strong> Out Manager Helsinn Healthcare S.A.<br />
Mr Raffaele Introzzi Senior Manager <strong>Licensing</strong> In Helsinn Healthcare S.A.<br />
Mr Alan Sheppard Princiapl Global Generics, Thought Leadership IMS<br />
Mr Elmar Schäfer Managing Director Insuline Medical <strong>GmbH</strong><br />
Mr David Garriga Business Development Manager Intas <strong>Pharma</strong>ceuticals Ltd<br />
Mr Xavier Verges Business Development Manager Isdin<br />
Mr Jim Villagran Director of Portfolio Management Isdin<br />
Mrs Maria José Rojo Head of Business Development J. Uriach y Compania, S.A.<br />
Mrs Mercedes Romero Fernandez‐Arroyo Business Development J. Uriach y Compania, S.A.<br />
Mr Renier van Dinter Manager New Business Development Benelux / Life Cycle Jannsen‐Cilag B.V.<br />
Mr Tomislav Kamenski Manager, New Business Development & Market Access Janssen<br />
Mr Alexandr Krajhanzl Director, New Business Development Europe Mid‐Sized Markets Janssen<br />
Mr Marc de Hullu Executive Director Alliance Management Janssen (<strong>Pharma</strong>ceutical companies of Johnson & Johnson)<br />
Mrs Kristina Wilton New Business Development Manager Janssen‐Cilag Ltd<br />
Ms Ana Kosoy Senior Project Manager Janus Development<br />
Mrs Ines Juste CEO Juste, S.A.Q.F.<br />
Mrs Arantxa Lobo Grana Business Development Manager Juste, S.A.Q.F.<br />
Mrs Mercedes Rodriguez Barrera Business Development & <strong>Licensing</strong> Director Juste, S.A.Q.F.<br />
Mr Jaume Rodó Vidal Export Director Kern <strong>Pharma</strong><br />
Mr Jordi Sarra Herrera <strong>Licensing</strong> Manager Kern <strong>Pharma</strong><br />
Mr Rod Coombs Commercial Director EU and MENA Kowa <strong>Pharma</strong>ceuticals Europe Co. Ltd<br />
Mr Faisal Darwazeh General Manager Labatec <strong>Pharma</strong><br />
Mr Pascal Auziere Strategic Business Development Director Laboratoires Urgo<br />
Ms Gema Martin Business Intelligence and <strong>Licensing</strong> Manager Laboratorios Casen‐Fleet, S.L.U.<br />
Mr Antonio Ventura Barba Business Development & R&D Director Laboratorios Casen‐Fleet, S.L.U.<br />
3
19‐21 September 2011 X IPLS, Barcelona Final Delegate List<br />
Mr Marc Alvarez <strong>Licensing</strong>‐In Manager Laboratorios Dr. Esteve<br />
Mrs Susanna Vera Agreements and Alliance Manager Laboratorios Dr. Esteve<br />
Mr Joaquim Colomé Business Development Spain & LATAM Laboratorios Menarini, S.A.<br />
Mr Miguel Castillo International Business Director Laboratorios Rovi<br />
Mr Iván López‐Belmonte Head of Corporate Development Laboratorios Rovi<br />
Ms Sonia Barrón Business Development Manager Laboratorios Rubió<br />
Mr Carlos Rubió Co‐General Manager Laboratorios Rubió, S.A.<br />
Mr Klaus Köhl Director Business Development & <strong>Licensing</strong> Labtec <strong>GmbH</strong><br />
Ms Astrid Richter Manager ‐ <strong>European</strong> Business Development & <strong>Licensing</strong> Lupin (Europe) Ltd<br />
Mr Ewan Livesey Lupin Atlantis Holdings SA<br />
Mr Peter Coull Director Marlborough <strong>Pharma</strong>ceuticals Ltd<br />
Mr Stefan Geelhaar International Business Development Manager Max Zeller Söhne AG<br />
Mr Jordi Martinez CEO Medifuture<br />
Mr Frank Buennig Managing Director Medinova AG<br />
Mrs Sharon Finch Director Medius Associates<br />
Mrs Bridget Lacey Medius Associates<br />
Mr Lars Börger Director Business Development Medtronic<br />
Mr Jasper van de Sande Manager Business Development Medtronic<br />
Mr Alex Moussa Director Biologics & Bio<strong>Pharma</strong>, Europe Medtronic International Trading Sàrl<br />
Mr Axel Bengsch Director Business Development Merck KGaA<br />
Mr Heiner Pieper Director Business Development Merck KGaA<br />
Ms Birgit Reitmaier Associate Director Merck KGaA<br />
Mrs Sandrine Alaphilippe <strong>Licensing</strong> Manager Merck Serono<br />
Mr Stephen Jarvis Associate Director Regional Business Development (Global BD) Merck Serono<br />
Mr Enrique Alvarez Strategy and Corporate Development Director Merck, S.L.<br />
Mr Miquel Raurell Business Develment and CRM Support Merck, S.L.<br />
Mr Francesco Del Rosso Business Development Manager Merck Merck, Sharp & Dohme<br />
Mr Enrique Cruz‐Jentoft Regional Director Business Development Merck, Sharp & Dohme, S.A.<br />
Mr Hing Kin Chan Chief Business Officer Merrion <strong>Pharma</strong>ceuticals Ltd<br />
Mrs Antje Deichmann Project Manager International <strong>Licensing</strong> Midas <strong>Pharma</strong> <strong>GmbH</strong><br />
Ms Andrea Hacker Director Business Development International Accounts Midas <strong>Pharma</strong> <strong>GmbH</strong><br />
Mr Mike Parnell Principal Consultant Mike Parnell Associates<br />
Mrs Margaret Beer Senior Director & Head, <strong>Licensing</strong> & External Research, Europe MSD<br />
Mr Manfred Horst Director, Scientific Liaison MSD<br />
Mr Rob Pinnock Director, Scientific Liaison MSD<br />
Mr Christian Schwenzfeier Manager Alliance Management MSD<br />
Ms Renate Asanger Head of Business Development MSD Sharp & Dohme <strong>GmbH</strong><br />
Ms Ann Dugdale <strong>European</strong> Alliance Manager Mundipharma International Ltd<br />
Mr John Roe Senior Business Development Manager Mundipharma International Ltd<br />
Ms Maria Peters Head of Commercial Projects Mylan<br />
Mr Hugues Benevent Senior Business Development & <strong>Licensing</strong> Manager Next<strong>Pharma</strong><br />
Mrs Maria Landwehr Nippon Shinyaku Co., Ltd<br />
Mr Katsuhiko Tougou Nippon Shinyaku Co., Ltd<br />
Ms Isabelle Trempe Senior Consultant Nomio Healthcare Business Development<br />
Ms Anissa Allal Business Analyst Nordic Group<br />
Mr Stéphane Altaba Business Development Manager Nordic Group<br />
Ms Allison McAulay Business Development Manager Norgine<br />
Mr Paul Pay Vice President, Corporate & Business Development Norgine<br />
4
19‐21 September 2011 X IPLS, Barcelona Final Delegate List<br />
Mr Hans‐Peter Frank Novartis<br />
Mrs Rosa‐Marta Domenech Head Business Development & <strong>Licensing</strong> Novartis Farmaceutica, S.A.<br />
Mrs Odavella Varela BD&L Specialist Novartis Farmaceutica, S.A.<br />
Mr Anthony Hörning Global BD&L, Alliance Management Novartis <strong>Pharma</strong><br />
Mrs Begona Carreno Global BD&L, Head S&E Resp. Novartis <strong>Pharma</strong> AG<br />
Mr Thomas Schmitz Head BD&L Region Europe Finance Novartis <strong>Pharma</strong> AG<br />
Mr Jens Aakersoe <strong>Licensing</strong> Director Novo Nordisk<br />
Mrs Birgitte Bjørn Budde IPR Manager License & Strategy Novozymes Biopharma UK Ltd<br />
Mr Carlos de Sousa Vice President <strong>Licensing</strong> Nycomed<br />
Mr Ragip Ziyal Senior Director Strategic Partnering, Business Development Nycomed <strong>GmbH</strong><br />
Ms Dorota Swietlicka Senior Director Business Development Nycomed International Management <strong>GmbH</strong><br />
Mr Markus Werner Director, Corporate <strong>Licensing</strong> Nycomed International Management <strong>GmbH</strong><br />
Ms Rosa Delgado Nycomed <strong>Pharma</strong><br />
Ms Irene Fernandez Nycomed <strong>Pharma</strong><br />
Mr Marc Kühnelt Managing Director Onkovis <strong>GmbH</strong><br />
Mr Alex Lewis Director of Corporate Activities and Strategies Oxford BioMedica<br />
Mr Mark Nawacki Vice President, Business & Corporate Development Paladin<br />
Mr Ignacio Faus CEO Palau <strong>Pharma</strong> S.A.<br />
Ms Heidi Sisniega Chief Business Officer Palau <strong>Pharma</strong> S.A.<br />
Mr Andrew Green Emerging Markets and Established Products, Pricing and Market Access Pfizer<br />
Mr Magi Abellan General Manager Médicament Pierre Fabre Ibérica, S.A.<br />
Mr Philippe Samouilla Business Development Pierre Fabre Ibérica, S.A.<br />
Mr Frederic Molin Corporate <strong>Licensing</strong> Manager Pierre Fabre Laboratories<br />
Ms Amela Omerbegovic Business Development & <strong>Licensing</strong> Manager Pierre Fabre <strong>Pharma</strong> <strong>GmbH</strong><br />
Mr Marc Raber Managing Director PMC <strong>Pharma</strong> Management Consultants <strong>GmbH</strong><br />
Mr Andrew Dean Director Present Value Ltd<br />
Mr Loic Kubitza Director Director, <strong>Pharma</strong>ceuticals & Life Sciences PricewaterhouseCoopers S.à Sàrl r.l.<br />
Mr Burkhard Sträter Professor<br />
Mr Ken Powell Executive Chairman Q Chip<br />
Mr Norbert Rau Raucon business development<br />
Mr Roger Davies Director Redpharma Limited<br />
Mr Morris Hosseini Principal Roland Berger Strategy Consultants<br />
Mr Guy Claude Director Out‐<strong>Licensing</strong> and Special Projects/Strategy and Business Development Sanofi‐Aventis<br />
Mr Sebastian Karrer Hesse Senior Manager Business Development Sanofi‐Aventis Deutschland <strong>GmbH</strong><br />
Mr Juergen Kutter Head of Business Development Sanofi‐Aventis Deutschland <strong>GmbH</strong><br />
Mr Laurence Cassarino Business Development & <strong>Licensing</strong> Sanofi‐aventis France<br />
Ms Clara Engroba Tejeiro Business Development Manager Sanofi‐aventis, S.A.<br />
Mr Santiago Negra Barrabeig Head of Business Development Sanofi‐aventis, S.A.<br />
Mr Xavier Santolaria Matehcio Business Development Manager Sanofi‐aventis, S.A.<br />
Mr Alexander Burstein Director Business Development Sanova <strong>Pharma</strong> <strong>GmbH</strong><br />
Mrs Kathrin Szimak Business Development Manager Sanova <strong>Pharma</strong> <strong>GmbH</strong><br />
Ms Johanna Knospe Director Business Development Europe Santen <strong>Pharma</strong>ceuticals<br />
Mr David Colpman SVP Business Development Shire <strong>Pharma</strong>ceuticals<br />
Ms Francesca Lianza Business Development Manager Siegfried Ltd<br />
Mr Marcello Pizzullo Head of Strategic Planning and Business Development SIFI SpA<br />
Mrs Antonella Cimatti Manager In‐<strong>Licensing</strong> ‐ Corporate Business Development Sigma‐Tau S.p.A.<br />
Mrs Francesca Polisano Out <strong>Licensing</strong> Associate Corporate Business Development Sigma‐Tau S.p.A.<br />
Mr Yves Decadt VP Business Development Skye<strong>Pharma</strong> AG<br />
5
19‐21 September 2011 X IPLS, Barcelona Final Delegate List<br />
Mrs Dominique Doyen Business Development Manager SPI <strong>Pharma</strong><br />
Mr Martin Siegmund Head of <strong>Licensing</strong> Spirig <strong>Pharma</strong> Ltd<br />
Ms Donna Hackett Commercial Director Stabilitech<br />
Mr Stewart Adkins Director Stewart Adkins Advisors Ltd<br />
Mrs Sylvie Fondanayche Head of Business Development Substipharm<br />
Ms Ute Steinbusch CEO Syntab Therapeutics<br />
Mr David Brady Vice President of Business Development Europe Takeda <strong>Pharma</strong>ceuticals Ltd<br />
Mr Ian Moules Senior Director ‐ Business Development Takeda <strong>Pharma</strong>ceuticals Ltd<br />
Mr Marco Manera President Teofarma srl<br />
Ms Janice McDonald Senior Manager, <strong>European</strong> Portfolio Development & <strong>Licensing</strong> Teva <strong>Pharma</strong>ceuticals Europe<br />
Mr Michael Tzimas Head of Portfolio and Business Development Teva UK Ltd<br />
Mr Alejandro Betancor‐Fernandez Senior <strong>Licensing</strong> Manager Teva/Ratiopharm<br />
Mr Thomas Hoegn Director Strategic Alliances TH Consulting<br />
Ms Eithne McShane Director, Business Development Therabel Europe Ltd<br />
Mr Dirk Reckert Business Development & <strong>Licensing</strong> Director Tillotts<br />
Mr Mario Schäfer Business Unit Manager Trifermed<br />
Mr Chandra Ondhia Managing Director Typharm Ltd<br />
Mr Rafael Cabrera Garcia UCB <strong>Pharma</strong><br />
Mr Hans‐Joachim Egly Director Business Development UCB <strong>Pharma</strong><br />
Mr Santiago Pradillo Alvarez UCB <strong>Pharma</strong><br />
Mr Eric Chesnel Commercial Director Unither <strong>Pharma</strong>ceuticals<br />
Mr Rubén Lupiáñez CEO Spain & Portugal Vemedia <strong>Pharma</strong><br />
Ms Gabrielle Gache Head BD&L and Marketing Services Vifor <strong>Pharma</strong><br />
Mr Kai Zwingenberger Director Commercial Development Vifor <strong>Pharma</strong><br />
Mr Xavier Gras Executive Director Vita Green Europa, S.A.<br />
Mr Nick Craig Finance Director Warner Chilcott<br />
Mr Prashanti Shah Medical Director Warner Chilcott<br />
Mr Lars Hallmayer Head of BD Marketing & Sales Welding <strong>GmbH</strong> & Co. KG<br />
Mr Ole Wiborg CEO Wiborg ApS<br />
Mr John Coates Director Business Development Europe Wockhardt<br />
Mr Raul Martin‐Ruiz Investment Director Ysios Capital Partners<br />
Ms Karen Wagner Venture Partner Ysios Capital Partners<br />
Mr Gianluca Basso Category Development Manager Zambon S.p.A.<br />
Mr Lorenzo Pradella General Manager Zcube srl<br />
6
Change language